Details of the Drug

General Information of Drug (ID: DM0DLGO)

• Drug Name: LY3090106
• Synonyms: Tibulizumab

Indication

Disease Entry	ICD 11	Status	REF
Sjogren syndrome	4A43.20	Phase 2/3	[1]
Rheumatoid arthritis	FA20	Phase 1	[2]

• Drug Type: Antibody
• Cross-matching ID: TTD ID: D09JVK
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT04563195) BAFF/IL-17 Bispecific Antibody Treatment in Subjects With Primary Sjogren's Syndrome (BAFF/IL-17). U.S. National Institutes of Health.
• [2] ClinicalTrials.gov (NCT01925157) A Study of LY3090106 in Healthy Participants and Participants With Rheumatoid Arthritis (RA). U.S. National Institutes of Health.